[
    [
        {
            "time": "2020-H1",
            "orginal_text": "2020年H1疫苗批签发报告：二季度批签发环比、同比显着提升 国产13价肺炎疫苗等表现强劲",
            "features": {
                "keywords": [
                    "疫苗",
                    "批签发",
                    "国产13价肺炎疫苗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "original_text": "2020年H1疫苗批签发报告：二季度批签发环比、同比显着提升 国产13价肺炎疫苗等表现强劲",
            "scores": {
                "News_content": "2020年H1疫苗批签发报告：二季度批签发环比、同比显着提升 国产13价肺炎疫苗等表现强劲",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2020-06-23",
            "orginal_text": "A股异动丨智飞生物(300122.SZ)涨超6%盘中破顶 重组新冠病毒疫苗启动Ⅱ期临床试验",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组新冠病毒疫苗",
                    "Ⅱ期临床试验"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "A股异动丨智飞生物(300122.SZ)涨超6%盘中破顶 重组新冠病毒疫苗启动Ⅱ期临床试验",
            "scores": {
                "News_content": "A股异动丨智飞生物(300122.SZ)涨超6%盘中破顶 重组新冠病毒疫苗启动Ⅱ期临床试验",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-23",
            "orginal_text": "智飞生物新冠疫苗启动Ⅱ期临床试验，评估安全性与免疫原性",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "Ⅱ期临床试验",
                    "安全性",
                    "免疫原性"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "智飞生物新冠疫苗启动Ⅱ期临床试验，评估安全性与免疫原性",
            "scores": {
                "News_content": "智飞生物新冠疫苗启动Ⅱ期临床试验，评估安全性与免疫原性",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-23",
            "orginal_text": "A股异动丨智飞生物(300122.SZ)涨超5%盘中破顶 重组新冠病毒疫苗启动Ⅱ期临床试验",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组新冠病毒疫苗",
                    "Ⅱ期临床试验"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "A股异动丨智飞生物(300122.SZ)涨超5%盘中破顶 重组新冠病毒疫苗启动Ⅱ期临床试验",
            "scores": {
                "News_content": "A股异动丨智飞生物(300122.SZ)涨超5%盘中破顶 重组新冠病毒疫苗启动Ⅱ期临床试验",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-23",
            "orginal_text": "智飞生物新冠疫苗启动二期临床试验，股价创历史新高",
            "features": {
                "keywords": [
                    "智飞生物",
                    "新冠疫苗",
                    "二期临床试验",
                    "股价历史新高"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "智飞生物新冠疫苗启动二期临床试验，股价创历史新高",
            "scores": {
                "News_content": "智飞生物新冠疫苗启动二期临床试验，股价创历史新高",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-23",
            "orginal_text": "智飞生物：重组新型冠状病毒疫苗启动Ⅱ期临床试验",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组新型冠状病毒疫苗",
                    "Ⅱ期临床试验"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "智飞生物：重组新型冠状病毒疫苗启动Ⅱ期临床试验",
            "scores": {
                "News_content": "智飞生物：重组新型冠状病毒疫苗启动Ⅱ期临床试验",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-23",
            "orginal_text": "半年报行情启动，一批预增超100%公司大涨，智飞生物启动新冠II期临床",
            "features": {
                "keywords": [
                    "半年报",
                    "智飞生物",
                    "新冠II期临床"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "半年报行情启动，一批预增超100%公司大涨，智飞生物启动新冠II期临床",
            "scores": {
                "News_content": "半年报行情启动，一批预增超100%公司大涨，智飞生物启动新冠II期临床",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-06-23",
            "orginal_text": "智飞生物重组新型冠状病毒疫苗启动Ⅱ期临床试验",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组新型冠状病毒疫苗",
                    "Ⅱ期临床试验"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "智飞生物重组新型冠状病毒疫苗启动Ⅱ期临床试验",
            "scores": {
                "News_content": "智飞生物重组新型冠状病毒疫苗启动Ⅱ期临床试验",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-06-23",
            "orginal_text": "【行情】疫苗板块开盘异动拉升，康泰生物涨7%，达安基因、辽宁成大、沃森生物、智飞生物等跟涨",
            "features": {
                "keywords": [
                    "疫苗板块",
                    "康泰生物",
                    "智飞生物"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【行情】疫苗板块开盘异动拉升，康泰生物涨7%，达安基因、辽宁成大、沃森生物、智飞生物等跟涨",
            "scores": {
                "News_content": "【行情】疫苗板块开盘异动拉升，康泰生物涨7%，达安基因、辽宁成大、沃森生物、智飞生物等跟涨",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-H1",
            "orginal_text": "【医药】2020年H1疫苗批签发：消费升级，新型疫苗渗透率持续提升——医药行业专题报告——中性（联系人：甘英健、陈晨、张山峰）",
            "features": {
                "keywords": [
                    "疫苗批签发",
                    "消费升级",
                    "新型疫苗",
                    "渗透率提升"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "original_text": "【医药】2020年H1疫苗批签发：消费升级，新型疫苗渗透率持续提升——医药行业专题报告——中性（联系人：甘英健、陈晨、张山峰）",
            "scores": {
                "News_content": "【医药】2020年H1疫苗批签发：消费升级，新型疫苗渗透率持续提升——医药行业专题报告——中性（联系人：甘英健、陈晨、张山峰）",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        }
    ]
]